RE: Hello 1p?30 May 2024 11:42
Basil, you seem a bit confused on a few things.
Firstly, July 10th news from NICE has nothing to do with the AIHL test. It's for CYP2C19. The hope is that it will be a FULL recommendation rather than another CONDITIONAL one.
Secondly, you appear to be working off the current mcap numbers. Once all the new shares are added I think the mcap will be more like £8.8m with about 555m shares in issue. That would maintain a share price of around 1.5p. Thus, after June 3rd and all shares are dumped on the market and we have a new mcap based on current value and all the new cash in the bank, then a share price of 15p would equate to mcap of £88m!! Don't think we're going to see that any time soon sadly.
For now, we really, really need Cheek to deliver a series of positive RNSs or this will slowly drop just under the placing price and enjoy a modest rise as we approach NICE news on July 10th. My own hope is that we see a rise up to about 5p (new mcap of about £30m). If NHS confirms sales of CYP2C19 tests as of Oct/Nov - the HNS has 3months to decide on its funding for this - then we may see a further rise.
imho I think all talk of anything more than 10p is for the birds, not because I think GDR can't achieve that or be worth it but because by that stage I think GDR will be bought out. The price of a take over with that good news in the bag and plenty of cash in the bank and MRN1 sales increasing could be very interesting. Sale price giving share holders 20p per share? Making this more than a 10 bagger from current value. Could be. Really could be.